BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 14, 2020
View Archived Issues
Phase I/II data presented for the SIIPL-PCV vaccine candidate
Read More
MRAP2 is accessory after the fact for appetite regulation
Read More
Human proteomics study gives new AD insights
Read More
Sanifit opens enrollment in phase III study of SNF-472 for calciphylaxis
Read More
Novartis opens phase III study of TQJ-230 in patients with cardiovascular disease
Read More
Oncolytic viruses 'wrapped' with tumor cell membranes show improved infectivity in cancer cells
Read More
Stem cell-based approach to spinal cord injuries developed
Read More
AMO Pharma opens enrollment in pivotal trial of AMO-02 for congenital myotonic dystrophy
Read More
BioMarin to initiate clinical testing of BMN-307 gene therapy
Read More
New preclinical data support PBI-05204 as a potential treatment for GBM
Read More
Topline data presented from TRILOGY 1 study of CaPre
Read More
RNF208 as a prognostic biomarker in TNBC
Read More
PTC Therapeutics describes new compounds for treating Huntington's disease
Read More
Jacobio-Beta Pharmaceuticals, Beijing Jacobio Pharmaceuticals patent BET inhibitors
Read More
Remdesivir as a potential new therapeutic option for MERS-CoV
Read More
Methylphenidate improves executive functioning in patients with VCI
Read More
MSD KK receives approval for Pifeltro for treating HIV-1 infection
Read More
New cardiac sarcomere inhibitors discovered at Cytokinetics
Read More
Zhejiang Vimgreen Pharma discloses adenosine A2A receptor antagonists
Read More
FDA clears IND for phase Ib/II study of AVB-500 in clear cell renal cell carcinoma
Read More
FDA approves Valtoco as acute treatment for seizures
Read More
Abeona initiates phase III study of EB-101 in recessive dystrophic epidermolysis bullosa
Read More
Neos studies NT-0502 in pilot phase I trial for chronic sialorrhea
Read More
Lilly opens enrollment in phase I study of CD73 inhibitor LY-3475070 in advanced cancer
Read More